GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » Shiller PE Ratio

West Pharmaceutical Services (FRA:WPS) Shiller PE Ratio : 74.86 (As of May. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services Shiller PE Ratio?

As of today (2024-05-04), West Pharmaceutical Services's current share price is €339.10. West Pharmaceutical Services's E10 for the quarter that ended in Mar. 2024 was €4.53. West Pharmaceutical Services's Shiller PE Ratio for today is 74.86.

The historical rank and industry rank for West Pharmaceutical Services's Shiller PE Ratio or its related term are showing as below:

FRA:WPS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 30.06   Med: 65.38   Max: 165.26
Current: 73.63

During the past years, West Pharmaceutical Services's highest Shiller PE Ratio was 165.26. The lowest was 30.06. And the median was 65.38.

FRA:WPS's Shiller PE Ratio is ranked worse than
87.59% of 282 companies
in the Medical Devices & Instruments industry
Industry Median: 27.07 vs FRA:WPS: 73.63

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Mar. 2024 was €1.426. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €4.53 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


West Pharmaceutical Services Shiller PE Ratio Historical Data

The historical data trend for West Pharmaceutical Services's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Shiller PE Ratio Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.84 122.41 144.14 57.23 72.61

West Pharmaceutical Services Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.34 84.75 79.46 72.61 79.82

Competitive Comparison of West Pharmaceutical Services's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Shiller PE Ratio falls into.



West Pharmaceutical Services Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

West Pharmaceutical Services's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=339.10/4.53
=74.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.426/129.4194*129.4194
=1.426

Current CPI (Mar. 2024) = 129.4194.

West Pharmaceutical Services Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.383 100.560 0.493
201409 0.334 100.428 0.430
201412 0.349 99.070 0.456
201503 0.416 99.621 0.540
201506 0.339 100.684 0.436
201509 0.018 100.392 0.023
201512 0.413 99.792 0.536
201603 0.269 100.470 0.347
201606 0.534 101.688 0.680
201609 0.445 101.861 0.565
201612 0.493 101.863 0.626
201703 0.757 102.862 0.952
201706 0.454 103.349 0.569
201709 0.562 104.136 0.698
201712 0.000 104.011 0.000
201803 0.470 105.290 0.578
201806 0.642 106.317 0.782
201809 0.626 106.507 0.761
201812 0.607 105.998 0.741
201903 0.646 107.251 0.780
201906 0.779 108.070 0.933
201909 0.681 108.329 0.814
201912 0.756 108.420 0.902
202003 0.896 108.902 1.065
202006 1.074 108.767 1.278
202009 0.925 109.815 1.090
202012 1.060 109.897 1.248
202103 1.672 111.754 1.936
202106 2.050 114.631 2.314
202109 1.964 115.734 2.196
202112 1.708 117.630 1.879
202203 2.079 121.301 2.218
202206 2.346 125.017 2.429
202209 1.606 125.227 1.660
202212 1.284 125.222 1.327
202303 1.728 127.348 1.756
202306 1.901 128.729 1.911
202309 2.005 129.860 1.998
202312 1.678 129.419 1.678
202403 1.426 129.419 1.426

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


West Pharmaceutical Services  (FRA:WPS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


West Pharmaceutical Services Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services (FRA:WPS) Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (FRA:WPS) Headlines